On February 1, 2023 Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, reported that Andrew Robbins, President and Chief Executive Officer, will participate in the following upcoming investor conferences in February (Press release, Cogent Biosciences, FEB 1, 2023, View Source [SID1234626700]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Guggenheim Healthcare Talks Idea Forum Oncology Day
Date/Time: Wednesday, February 8, 2023 at 10:10 a.m. ET
SVB Securities Global Biopharma Conference:
Date/Time: Tuesday, February 14, 2023 at 9:20 a.m. ET
A live webcast of each event can be accessed on the Investors & Media page of Cogent’s website at View Source A replay of the webcasts will be available approximately two hours after the completion of the events and will be archived for up to 30 days.